A study of three malaria drugs in healthy adults
Part of Infections clinical trials.
This trial tests a combination of three malaria medicines in healthy volunteers to see how safe they are and how the body processes them. If you are a healthy non-smoker, you may be able to help researchers understand these drugs better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 60 years old.
- You must weigh between 45 and 85 kg (99 to 187 pounds).
- You must be a non-smoker.
- If you are a woman, you must not be pregnant, trying to get pregnant, or breastfeeding, and agree to use effective birth control if needed.
- You must have no history of heart problems or abnormal heart rhythms, and your ECG (heart test) must be normal.
- You must be willing to avoid alcohol for 48 hours before each dose until the end of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This study compares two experimental malaria vaccines to see how safe they are and how well they protect adults. It may help future malaria prevention, and you would be closely monitored, including a malaria “challenge” test if you qualify.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study tests new combinations of antimalarial drugs to better cure P. vivax malaria, a type of malaria parasite. You would receive experimental drug combinations and be monitored for about 6 months to see if they work and are safe.
This study tests a generic version of a malaria medicine (sulfadoxine/pyrimethamine) to see if it works the same as the original. Healthy volunteers take a single dose and have their blood checked over time.
This study compares a combination of three medicines to treat uncomplicated malaria, to see if it works as well and is as well tolerated as a two-medicine combination. You may join if you have a specific type of malaria infection in a mild form and meet safety requirements.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.